COREY WHITESIDES: Open Payments
NPI 1689019614 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,472 in 124 payments from 17 companies in 2025. Trend: 2023 $3,020 · 2024 $2,982 · 2025 $7,472
Consulting: $3,600Food & beverage: $2,573Travel & lodging: $1,199Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $5,652 |
| ABBVIE INC. | 22 | $466 |
| Novartis Pharmaceuticals Corporation | 22 | $374 |
| UCB, Inc. | 6 | $273 |
| Lilly USA, LLC | 14 | $193 |
| LEO Pharma Inc. | 3 | $86 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| Amgen Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| PFIZER INC. | 3 | $67 |
Products named: TREMFYA, SKYRIZI, COSENTYX, Bimzelx, TALTZ, RINVOQ, DUPIXENT, Sotyktu.
Industry payments across MO — which companies pay providers there.
